Sirolimus and Familial Adenomatous Polyposis (FAP)

NCT03095703 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Adenomatous Polyposis Coli

Interventions

DRUG: Sirolimus

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)